IIL rolls out India’s 1st indigenous Hepatitis-A vax Havisure

Indian Immunologicals Ltd rolls out Havisure, India's first indigenous Hepatitis-A vaccine. The two-dose inactivated virus vaccine, developed over eight years, is priced at Rs 2,150 per dose. Extensive clinical trials have shown that Havisure is safe and efficacious for pediatric, adolescent, and adult use.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/idvbnos

Comments

Popular posts from this blog

Centre’s spend may rise by Rs 2 lakh crore in current fiscal

FPIs infuse Rs 9,000 crore in equities in November; inflow in debt at 6-year high

Sebi to review norms for penalty disclosure